Literature DB >> 6487894

The effects of verapamil, prenylamine, flunarizine and cinnarizine on coronary artery occlusion-induced arrhythmias in anaesthetized rats.

O Fagbemi, K A Kane, F M McDonald, J R Parratt, A L Rothaul.   

Abstract

In male rats, anaesthetized with pentobarbitone, ligation of the main left coronary artery causes an early phase of ventricular arrhythmias which last about 30 min. In approximately 60% of control animals, ventricular fibrillation occurs but since spontaneous reversion to sinus rhythm may occur, mortality is of the order of 30%. When administered intravenously 15 min prior to ligation, verapamil (0.01 and 0.05 mg kg-1), prenylamine (0.5 mg kg-1), flunarizine (0.1, 0.25, 0.5 and 1.0 mg kg-1) and cinnarizine (0.25, 0.5 and 1.0 mg kg-1) protected against these arrhythmias. Higher doses of verapamil (0.1 and 0.5 mg kg-1), prenylamine (5 mg kg-1) and flunarizine (2.5 mg kg-1) did not afford a similar protection and mortality was increased to or above control values. Death was due in prenylamine-treated rats to atrioventricular block leading to asystole whereas in those administered verapamil or flunarizine it was a consequence of persistent ventricular fibrillation. Prior to ligation, a sustained fall in mean arterial blood pressure was observed only following the administration of the highest doses of prenylamine, flunarizine and cinnarizine. Heart rate was reduced by administration of only the highest dose of prenylamine. These studies show that although the four calcium antagonists studied, i.e. verapamil, prenylamine, flunarizine and cinnarizine do suppress ischaemia-induced arrhythmias, this protective effect may be limited to a narrow concentration range.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6487894      PMCID: PMC1987188          DOI: 10.1111/j.1476-5381.1984.tb10146.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  14 in total

1.  Inotropic and electrophysiological actions of verapamil and D 600 in mammalian myocardium. III. Effects of the optical isomers on transmembrane action potentials.

Authors:  R Bayer; D Kalusche; R Kaufmann; R Mannhold
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

2.  Comparative study of the effects of flunarizine and cinnarizine on smooth muscles and cardiac tissues.

Authors:  J M Van Nueten; P A Janssen
Journal:  Arch Int Pharmacodyn Ther       Date:  1973-07

3.  Prevention of ventricular fibrillation induced by coronary ligation.

Authors:  A J Kaumann; P Aramendía
Journal:  J Pharmacol Exp Ther       Date:  1968-12       Impact factor: 4.030

4.  The haemodynamic and metabolic effects of MG 8926, a prospective antidysrhythmic and antianginal agent.

Authors:  R J Marshall; J R Parratt
Journal:  Br J Pharmacol       Date:  1977-02       Impact factor: 8.739

5.  The effects of nifedipine on acute experimental myocardial ischemia and infarction in dogs.

Authors:  A P Selwyn; E Welman; K Fox; P Horlock; T Pratt; M Klein
Journal:  Circ Res       Date:  1979-01       Impact factor: 17.367

6.  A protective effect of verapamil on hypoxic heart muscle.

Authors:  W G Nayler; A Grau; A Slade
Journal:  Cardiovasc Res       Date:  1976-11       Impact factor: 10.787

7.  Effects of verapamil on infarct size following experimental coronary occlusion.

Authors:  H J Smith; B N Singh; H D Nisbet; R M Norris
Journal:  Cardiovasc Res       Date:  1975-07       Impact factor: 10.787

8.  Protective effect of verapamil on vulnerability to ventricular fibrillation during myocardial ischaemia and reperfusion.

Authors:  W W Brooks; R L Verrier; B Lown
Journal:  Cardiovasc Res       Date:  1980-05       Impact factor: 10.787

9.  Effect of drugs on conduction delay and incidence of ventricular arrhythmias induced by acute coronary occlusion in dogs.

Authors:  V Elharrar; W E Gaum; D P Zipes
Journal:  Am J Cardiol       Date:  1977-04       Impact factor: 2.778

10.  Coronary artery ligation in anesthetized rats as a method for the production of experimental dysrhythmias and for the determination of infarct size.

Authors:  C Clark; M I Foreman; K A Kane; F M McDonald; J R Parratt
Journal:  J Pharmacol Methods       Date:  1980-06
View more
  9 in total

1.  Antiarrhythmic effects of a benzothiazine derivative (SD-3211) and its stereoisomer (SA3212) in anaesthetized rats and isolated perfused rat hearts compared with bepridil.

Authors:  M Fukuchi; T Uematsu; S Nagashima; M Nakashima
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-06       Impact factor: 3.000

2.  The mechanism of action of the optical enantiomers of verapamil against ischaemia-induced arrhythmias in the conscious rat.

Authors:  M J Curtis; M J Walker
Journal:  Br J Pharmacol       Date:  1986-09       Impact factor: 8.739

3.  Interactions of DPI 201-106, a novel cardiotonic agent, with cardiac calcium channels.

Authors:  P K Siegl; M L Garcia; V F King; A L Scott; G Morgan; G J Kaczorowski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-12       Impact factor: 3.000

4.  Pharmacokinetics and antiarrhythmic activity of ajmaline in rats subjected to coronary artery occlusion.

Authors:  Y Hashimoto; R Hori; K Okumura; M Yasuhara
Journal:  Br J Pharmacol       Date:  1986-05       Impact factor: 8.739

5.  The mechanism of action of calcium antagonists on arrhythmias in early myocardial ischaemia: studies with nifedipine and DHM9.

Authors:  M J Curtis; M J Walker
Journal:  Br J Pharmacol       Date:  1988-08       Impact factor: 8.739

6.  High-content phenotypic assay for proliferation of human iPSC-derived cardiomyocytes identifies L-type calcium channels as targets.

Authors:  Laura A Woo; Svyatoslav Tkachenko; Mei Ding; Alleyn T Plowright; Ola Engkvist; Henrik Andersson; Lauren Drowley; Ian Barrett; Mike Firth; Peter Akerblad; Matthew J Wolf; Stefan Bekiranov; David L Brautigan; Qing-Dong Wang; Jeffrey J Saucerman
Journal:  J Mol Cell Cardiol       Date:  2018-12-28       Impact factor: 5.000

7.  Actions of the verapamil analogues, anipamil and ronipamil, against ischaemia-induced arrhythmias in conscious rats.

Authors:  M J Curtis; M J Walker; T Yuswack
Journal:  Br J Pharmacol       Date:  1986-06       Impact factor: 8.739

8.  Cardiac Rhythm and Molecular Docking Studies of Ion Channel Ligands with Cardiotoxicity in Zebrafish.

Authors:  Bonifasius Putera Sampurna; Fiorency Santoso; Jia-Hau Lee; Wen-Hao Yu; Chin-Chung Wu; Gilbert Audira; Stevhen Juniardi; Jung-Ren Chen; Ying-Ting Lin; Chung-Der Hsiao
Journal:  Cells       Date:  2019-06-10       Impact factor: 6.600

9.  Anti-Inflammatory and Anti-Angiogenesis Effects of Verapamil on Rat Air Pouch Inflammation Model.

Authors:  Tahereh Eteraf-Oskouei; Sevda Mikaily Mirak; Moslem Najafi
Journal:  Adv Pharm Bull       Date:  2017-12-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.